FBXW7 and cancer: FBXW7 can act as a monomer or a dimer, however dimerization is important for binding of protein with a weak CPD such as cyclin E. In cancer cells FBXW7 mutations are often heterozygote, which would allow the formation of homodimers for both wild type and mutated forms as well as heterodimers.